Process for reducing blood sugar concentration in a mammal

Details Process for reducing blood sugar concentration in a mammal Process for reducing blood sugar concentration in a mammal

1976-10-20

1978-06-06

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Recombinant or stably-transformed bacterium encoding one or...

A61K 3118

Patent

active

040937410

ABSTRACT:
A new class of arylsulfonylcarbamoyl-1,3-cyclohexanediones and arylsulfonylcarbamoyl-1,3-dicarbonylacyclic compounds are disclosed. These substances have hypoglycemic or hyperglycemic properties and are of value in controlling abnormal blood sugar levels. The arylsulfonylcarbamoyl derivatives of 1,3-dicarbonylalicyclic and acyclic compounds are prepared by reacting an arylsulfonylisocyanate with a 1,3-dicarbonylalicyclic or acyclic reactant. Typical embodiments are 2-(N-p-chlorobenzenesulfonylcarbamoyl)-5,5-dimethylcyclohexane-1,3-dione and 5-(1-ethylpropyl)-2-(N-p-chlorobenzenesulfonylcarbamoyl)-1,3-cyclohexanedi one.

REFERENCES:
patent: 3298917 (1967-01-01), Bicking
patent: 3917718 (1975-11-01), Collins

Affiliated with

Also associated with

Rating

Process for reducing blood sugar concentration in a mammal does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for reducing blood sugar concentration in a mammal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for reducing blood sugar concentration in a mammal will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1493572